Studies Currently Being Performed by Retinal Consultants With Central Texas Eye Center

Alcon C-01-99:
Anecortave Acetate (Retaane) vs. Visudyne in classic choroidal neovascularization
Status: *Near completion*, Closed enrollment

Alcon C-02-60:
Anecortave Acetate (Retaane) vs. placebo in wet age related macular degeneration
Status: Ongoing, Open enrollment

Genentech “MARINA”:
RhuFab (Lucentis) vs. placebo in minimally classic/occult choroidal neovascularization
Status: Ongoing, closed enrollment

Genentech “ANCHOR”:
RhuFab (Lucentis vs. Visudyne in predominantly Classic choroidal neovascularization
Status: Ongoing, closed enrollment

Genentech “PIER”
RhuFab (Lucentis) Q1mos x 3mos then Q3mos vs. placebo in choroidal neovascularization
Status: Ongoing, closed enrollment

Genentech “HORIZON”
RhuFab (Lucentis) Open label for choroidal neovascularization
Status: Open enrollment (for MARINA, ANCHOR and PIER subjects)

Allergan 206207-009:
DEX PS DDS (Posurdex) vs. placebo for edema due to branch retinal vein occlusion/central retinal vein occlusion
Status: Ongoing, Open enrollment

Allergan 206207-011:
DEX PS DDS (Posurdex) vs. placebo for diabetic macular edema
Status: Open enrollment

EyeTech EOP1011:
DEX PS DDS (Posurdex) vs. placebo for diabetic macular edema
Status: Open enrollment

EyeTech EOP1012:
Macugen and Visudyne vs. Macugen in predominantly classic central neovascularization
Status: Ongoing, Closed enrollment

DRCR-JAEB #1-A
(NIH/NEI) Modified ETDRS Laser vs. Mild Macular Grid laser in diabetic macular edema
Status: Ongoing, Closed enrollment

DRCR-JAEB Protocol B:
(NIH/NEI) Intravitreal Triamcinolone vs. laser in diabetic macular edema
Status: Ongoing, Closed enrollment